Completed
CTN 214: Effect of a one-year course of HAART in acute/early HIV
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
Learn MoreCompleted
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
Learn MoreTerminated
An observational study of Kaletra®/Celsentri® combination therapy
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.